🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Heterozygous Familial Hypercholesterolemia (HeFH)

The ORIGIN-FH Study NCT07470723NA1 site📍 Madison University of Wisconsin, Madison · Tests: Screening for FH Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia NCT06597019Phase 366 sites📍 San Francisco📍 San Francisco📍 Washington D.C. Novartis Pharmaceuticals · Tests: Inclisiran, Placebo A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) NCT07465263Phase 31 site📍 Beijing CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2053 Injection, Placebo Injection A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172Phase 117 sites📍 Hialeah📍 Jacksonville📍 Orlando CRISPR Therapeutics AG · Tests: CTX310 Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia NCT06634160n/a3 sites📍 Angers📍 Nantes📍 Rennes Nantes University Hospital · Tests: Fibroscan, Sample collection Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies NCT05682378Phase 352 sites📍 Boca Raton📍 New York📍 Cincinnati Novartis Pharmaceuticals · Tests: Inclisiran A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029) NCT07058077Phase 2, Phase 347 sites📍 Wilmington📍 Washington D.C.📍 Boca Raton Merck Sharp & Dohme LLC · Tests: Enlicitide Decanoate, Placebo "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)" NCT07427472NA3 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Coronary computed tomography angiography
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy